Home
About Us
Team
Investment Focus
Laboratory Products
Laboratory Services
Contract Manufacturing
Pharma Services
Specialty Pharma
Portfolio
News
Contact
News
January 17, 2020
January 17, 2020
Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services
January 13, 2020
January 13, 2020
Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners
December 16, 2019
December 16, 2019
Ampersand Capital Partners Acquires Peptides International And Merges Company With New England Peptide
December 4, 2019
December 4, 2019
Canopy Biosciences Acquires Core Diagnostics
November 13, 2019
November 13, 2019
Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply
November 7, 2019
November 7, 2019
StageBio and Alizée Pathology Merge
October 31, 2019
October 31, 2019
Mesa Labs Acquires Gyros Protein Technologies
October 30, 2019
October 30, 2019
Arranta Bio announces $82M in new funding, and a strategic partnership with Thermo Fisher Scientific
October 17, 2019
October 17, 2019
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners
October 7, 2019
October 7, 2019
New England Peptide Receives Growth Equity Investment From Ampersand Capital Partners
Prev page
1
2
3
4
...
12
Next page
